title: Ocular melanoma.
abstract: The eye is the second most common site for primary melanoma after the skin. An ophthalmologic evaluation should be an integral aspect of melanoma screening that is often not even considered by nonophthalmologists. Delays or failures to make an accurate and early diagnosis can have grave consequences. Early recognition and diagnosis, before the tumor has progressed into an advanced process with a poor prognosis, can often result in complete cures through early interventional treatments. It is imperative that physicians adequately understand and appropriately examine or refer patients for appropriate screening for ocular melanoma as a routine practice in screening for melanoma. This article is intended to raise the clinical awareness of the practicing physician regarding this disease.
authors.affiliation: Department of Dermatology, University of Texas Health Science Center at Houston, USA.
authors.forename: J C
authors.initials: JC
authors.lastname: Cather
authors.forename: J C
authors.initials: JC
authors.lastname: Cather
authors.forename: C N
authors.initials: CN
authors.lastname: Soparkar
authors.forename: B R
authors.initials: BR
authors.lastname: Nelson
mesh_terms: D005123:Eye / Q000033:anatomy & histology; D005134:Eye Neoplasms / Q000175:diagnosis* / Q000473:pathology; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary; D008545:Melanoma / Q000175:diagnosis* / Q000473:pathology; D011379:Prognosis